Fundz

Who to call at Asgard Therapeutics, and when

Fundz watches for the moments Asgard Therapeutics starts buying, and tells you who to reach.

  • An alert the day Asgard Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Asgard Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Asgard Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Asgard Therapeutics receives €2.5M grant from European Innovation Council Accelerator to advance cancer immunotherapy program.

Nov 21, 2026
LundBiotechnologyFinancial ServicesHealth Care

Description

Asgard Therapeutics, a Lund, Sweden-based biotech company, received a €2.5M grant from the European Innovation Council (EIC) Accelerator. The company will use the funds to accelerate preparatory work for its lead program, AT-108, advancing toward First-in-Human clinical trials in 2027. Asgard develops gene therapy products using direct cell reprogramming technologies to trigger personalized anti-cancer immune responses. The platform uses a replication-deficient adenoviral vector to reprogram tumor cells into antigen-presenting dendritic-like cells.

Quick answer

Asgard Therapeutics receives €2.5M grant from European Innovation Council Accelerator to advance cancer immunotherapy program. (November 21, 2026). Asgard Therapeutics is based in Lund, Skåne County, Sweden.

What agreement did Asgard Therapeutics announce on November 21, 2026?
Asgard Therapeutics, a Lund, Sweden-based biotech company, received a €2.5M grant from the European Innovation Council (EIC) Accelerator. The company will use the funds to accelerate preparatory work for its lead program, AT-108, advancing toward First-in-Human clinical trials in 2027.
What does Asgard Therapeutics do?
Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies.
Where is Asgard Therapeutics based?
Asgard Therapeutics is based in Lund, Skåne County, Sweden.
Which similar companies announced agreements around the same time?
United Wholesale Mortgage (November 12, 2026), Danaher (October 18, 2026), ViTAA Medical Solutions (November 20, 2026) and Des Moines University (November 20, 2026) also announced agreements within 45 days of Asgard Therapeutics.

Source: Fundz verified event record.

Other recent agreements in Financial Services and Biotechnology

Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.

Company Information

Company

Asgard Therapeutics

Location

Lund, Skåne County, Sweden

About

Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biological properties of professional antigen presenting cells. Backed by Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden, Asgard Therapeutics aims to build a pipeline of personalized cancer immunotherapies optimized to each unique patient.

Related People

Cristiana
Likely contact at this company
••••••••@••••••••

See Cristiana's verified email →

Fabio
Senior decision-maker at this company
••••••••@••••••••

See Fabio's verified email →

Cristiana
Senior decision-maker at this company
••••••••@••••••••

See Cristiana's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Asgard Therapeutics's next move

Learn about Strategic plan

Asgard Therapeutics signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.